EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions

Cinara Regina A V Monteiro, Eduarda G Bogea iD, Carmem D L Campos iD, José L Pereira-Filho iD, Viviane S S Almeida, André A M Vale, Ana Paula S Azevedo-Santos iD, Valério Monteiro-Neto iD

Nutrients · 23.01.2026 · 18 (3) · 372

DOI: 10.3390/nu18030372 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 23.01.2026. Verfasst von Cinara Regina A V Monteiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center of Biological and Health Sciences, Federal University of Maranhão, Bacanga Campus, São Luís 65080-805, MA, Brazil. Hauptthemen laut MEDLINE: Prebiotics, Gastrointestinal Microbiome, Gastrointestinal Tract. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão, Coordenação de Aperfeicoamento de Pessoal de Nível Superior, National Council for Scientific and Technological Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Prebiotics, which are non-digestible compounds that selectively modulate gut microbiota, are recognized for their potential to promote host health. Although their bifidogenic effect is well documented, a systematic synthesis of how this microbial modulation translates into clinical gastrointestinal (GI) and metabolic outcomes across diverse populations is needed. This review aims to integrate mechanistic insights with clinical evidence to elucidate the pathway from prebiotic structures to tangible health benefits.

Methods

This comprehensive narrative review details the structural properties of major prebiotics (e.g., inulin, FOS, and GOS) that govern their fermentation and the production of short-chain fatty acids (SCFAs). To evaluate clinical efficacy, an analysis of 22 randomized controlled trials from the past decade was conducted, focusing on human studies that utilized ISAPP-recognized prebiotics as the sole intervention.

Results

The analysis confirms that prebiotic supplementation consistently increased the abundance of beneficial bacteria (e.g., Bifidobacterium and Lactobacillus) and SCFA production. These changes are associated with significant clinical improvements, including enhanced stool frequency and consistency, strengthened intestinal barrier function, and modulated immune responses. Benefits have been documented in healthy individuals, children, the elderly, and those with conditions such as constipation, metabolic syndrome, and antibiotic-associated dysbiosis. However, significant inter-individual variability in response was evident, and the study designs showed notable heterogeneity in prebiotic type, dosage, and duration.

Conclusions

Prebiotics are effective modulators of gut health, driving clinical benefits through selective microbial fermentation and SCFA production. The documented heterogeneity and variability highlight the need for future research to focus on personalized nutritional strategies. Key priorities include standardizing intervention protocols, elucidating dose–response relationships, integrating multi-omics data to link taxonomy to function, and exploring novel applications such as synbiotic formulations and gut–brain axis modulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrebioticsGastrointestinal MicrobiomeGastrointestinal TractHumansFatty Acids, VolatileIntestinal Barrier FunctionFermentationRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

gastrointestinal healthgut microbiotaintestinal barrierpersonalized nutritionprebioticsrandomized controlled trialsshort-chain fatty acids (SCFAs)synbiotics

Substanzen

PrebioticsFatty Acids, Volatile

Autor:innen und Institutionen

  • Center of Biological and Health Sciences, Federal University of Maranhão, Bacanga Campus, São Luís 65080-805, MA, Brazil.
  • School of Physical Therapy, Florence University Center, São Luís 65.020-490, MA, Brazil.

ORCID-Profile: Eduarda G Bogea, Carmem D L Campos, José L Pereira-Filho, Ana Paula S Azevedo-Santos, Valério Monteiro-Neto

Förderung

  • Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão
  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • National Council for Scientific and Technological Development
  • FAPEMA—Foundation for Research and Scientific and Technological Development Support of Maranhão
  • CAPES—Coordination for the Improvement of Higher Education Personnel
  • CNPq—National Council for Scientific and Technological Development
  • FitoAmazônia Research Network

Zitieren

APA

Monteiro, C. R. A. V., Bogea, E. G., Campos, C. D. L., Pereira-Filho, J. L., Almeida, V. S. S., Vale, A. A. M., Azevedo-Santos, A. P. S., & Monteiro-Neto, V. (2026). Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions. Nutrients, 18(3), 372. https://doi.org/10.3390/nu18030372

Vancouver

Monteiro CRAV, Bogea EG, Campos CDL, Pereira-Filho JL, Almeida VSS, Vale AAM, et al. Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions. Nutrients. 2026;18(3):372. doi:10.3390/nu18030372

BibTeX
@article{Monteiro2026,
  author = {Monteiro, Cinara Regina A V and Bogea, Eduarda G and Campos, Carmem D L and Pereira-Filho, José L and Almeida, Viviane S S and Vale, André A M and Azevedo-Santos, Ana Paula S and Monteiro-Neto, Valério},
  title = {Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {3},
  pages = {372},
  doi = {10.3390/nu18030372}
}
Kostenlos starten →